✨ New Arrivals Just Dropped!Explore
NFH Boswellia SAP, 90 Capsules
HomeStore

NFH Boswellia SAP, 90 Capsules

NFH Boswellia SAP, 90 Capsules

*Must have Practitioner recommendation before use*

 

*WE MAY VERIFY THE INFORMATION GIVEN*

NFH Boswellia SAP Details

Boswellia SAP provides a standardized dose of Boswellia serrata oleogum resin extract, used in traditional medicine for centuries for a number of ailments related to acute and chronic inflammation. Boswellic acids, especially 11‑keto-β‑boswellic acid (KBA) and 3‑O‑acetyl-11‑ketoβ‑boswellic acid (AKBA) are the main active constituents responsible for the anti-inflammatory effects of B.  serrata, are specific inhibitors of 5‑lipoxygenase (5‑LOX), and thereby suppress leukotriene synthesis. Boswellia SAP can be used to maintain healthy inflammatory response and reduce pain associated with osteo‑ and rheumatoid arthritis. Boswellia SAP could be very useful in the management of inflammatory bowel diseases (IBD) and to improve quality of life in patients during the remission phase. In addition, Boswellia SAP could help improve lung and immune function in asthma patients. Boswellia SAP can also be used to reduce peritumoural brain oedema, support neurorecovery following traumatic brain injury (TBI), and potentially as an adjunctive support in cancer treatment. Evidence supports the use of Boswellia SAP for promoting clinical benefits in blood-glucose control and lipid metabolism in type 2 diabetic patients.

  • Boswellia SAP can be used to promote healthy inflammatory responses. 
  • Boswellia SAP can help relieve pain associated with arthritis. 
  • Boswellia SAP can help manage IBD and improve the quality of life in patients. 
  • Boswellia SAP can improve lung and immune function in asthma patients.
  • Boswellia SAP can be used to reduce peritumoural brain oedema and support neurorecovery following traumatic brain injury. 
  • Boswellia SAP can be used as an adjunctive support in cancer treatment. 
  • Boswellia SAP can help control blood glucose levels and improve lipid metabolism in type 2 diabetic patients.
$6.40

Original: $18.29

-65%
NFH Boswellia SAP, 90 Capsules

$18.29

$6.40

NFH Boswellia SAP, 90 Capsules

*Must have Practitioner recommendation before use*

 

*WE MAY VERIFY THE INFORMATION GIVEN*

NFH Boswellia SAP Details

Boswellia SAP provides a standardized dose of Boswellia serrata oleogum resin extract, used in traditional medicine for centuries for a number of ailments related to acute and chronic inflammation. Boswellic acids, especially 11‑keto-β‑boswellic acid (KBA) and 3‑O‑acetyl-11‑ketoβ‑boswellic acid (AKBA) are the main active constituents responsible for the anti-inflammatory effects of B.  serrata, are specific inhibitors of 5‑lipoxygenase (5‑LOX), and thereby suppress leukotriene synthesis. Boswellia SAP can be used to maintain healthy inflammatory response and reduce pain associated with osteo‑ and rheumatoid arthritis. Boswellia SAP could be very useful in the management of inflammatory bowel diseases (IBD) and to improve quality of life in patients during the remission phase. In addition, Boswellia SAP could help improve lung and immune function in asthma patients. Boswellia SAP can also be used to reduce peritumoural brain oedema, support neurorecovery following traumatic brain injury (TBI), and potentially as an adjunctive support in cancer treatment. Evidence supports the use of Boswellia SAP for promoting clinical benefits in blood-glucose control and lipid metabolism in type 2 diabetic patients.

  • Boswellia SAP can be used to promote healthy inflammatory responses. 
  • Boswellia SAP can help relieve pain associated with arthritis. 
  • Boswellia SAP can help manage IBD and improve the quality of life in patients. 
  • Boswellia SAP can improve lung and immune function in asthma patients.
  • Boswellia SAP can be used to reduce peritumoural brain oedema and support neurorecovery following traumatic brain injury. 
  • Boswellia SAP can be used as an adjunctive support in cancer treatment. 
  • Boswellia SAP can help control blood glucose levels and improve lipid metabolism in type 2 diabetic patients.

Product Information

Shipping & Returns

Description

*Must have Practitioner recommendation before use*

 

*WE MAY VERIFY THE INFORMATION GIVEN*

NFH Boswellia SAP Details

Boswellia SAP provides a standardized dose of Boswellia serrata oleogum resin extract, used in traditional medicine for centuries for a number of ailments related to acute and chronic inflammation. Boswellic acids, especially 11‑keto-β‑boswellic acid (KBA) and 3‑O‑acetyl-11‑ketoβ‑boswellic acid (AKBA) are the main active constituents responsible for the anti-inflammatory effects of B.  serrata, are specific inhibitors of 5‑lipoxygenase (5‑LOX), and thereby suppress leukotriene synthesis. Boswellia SAP can be used to maintain healthy inflammatory response and reduce pain associated with osteo‑ and rheumatoid arthritis. Boswellia SAP could be very useful in the management of inflammatory bowel diseases (IBD) and to improve quality of life in patients during the remission phase. In addition, Boswellia SAP could help improve lung and immune function in asthma patients. Boswellia SAP can also be used to reduce peritumoural brain oedema, support neurorecovery following traumatic brain injury (TBI), and potentially as an adjunctive support in cancer treatment. Evidence supports the use of Boswellia SAP for promoting clinical benefits in blood-glucose control and lipid metabolism in type 2 diabetic patients.

  • Boswellia SAP can be used to promote healthy inflammatory responses. 
  • Boswellia SAP can help relieve pain associated with arthritis. 
  • Boswellia SAP can help manage IBD and improve the quality of life in patients. 
  • Boswellia SAP can improve lung and immune function in asthma patients.
  • Boswellia SAP can be used to reduce peritumoural brain oedema and support neurorecovery following traumatic brain injury. 
  • Boswellia SAP can be used as an adjunctive support in cancer treatment. 
  • Boswellia SAP can help control blood glucose levels and improve lipid metabolism in type 2 diabetic patients.